Narjust Duma
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 36
- Lung Cancer Research Studies 8
- Cancer Immunotherapy and Biomarkers 8
- Global Cancer Incidence and Screening 7
-
- Diversity and Career in Medicine 17
- Co-authors
- Julian R. Molina (6 shared papers)Rafael Santana-Dávila (1 shared paper)Jesus Vera Aguilera (7 shared papers)Yucai Wang (8 shared papers)Aaron S. Mansfield (9 shared papers)Alex A. Adjei (10 shared papers)Þorvarður R. Hálfdánarson (3 shared papers)Jonas Paludo (8 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)The Oncologist (8 papers)JAMA Oncology (4 papers)Blood (2 papers)JCO Oncology Practice (2 papers)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Narjust Duma
87 papers receiving 3.4k citations
Narjust Duma's Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 1.2k
- Cancer Research 383
- Pulmonary and Respiratory Medicine 808
- Public Health, Environmental and Occupational Health 372
- Gender Studies 138
Countries citing papers authored by Narjust Duma
This map shows the geographic impact of Narjust Duma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjust Duma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjust Duma more than expected).
Fields of papers citing papers by Narjust Duma
This network shows the impact of papers produced by Narjust Duma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjust Duma. The network helps show where Narjust Duma may publish in the future.
Co-authors
The 25 scholars most cited alongside Narjust Duma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment Hit paper breakdown → | 2019 | 1575 |
| 2 | Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials Hit paper breakdown → | 2019 | 628 |
| 3 | Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years Hit paper breakdown → | 2017 | 290 |
| 4 | 2019 | 103 | |
| 5 | 2019 | 98 | |
| 6 | 2019 | 55 | |
| 7 | 2020 | 48 | |
| 8 | 2018 | 43 | |
| 9 | 2018 | 37 | |
| 10 | 2021 | 36 | |
| 11 | 2021 | 32 | |
| 12 | 2022 | 26 | |
| 13 | 2021 | 26 | |
| 14 | 2021 | 26 | |
| 15 | 2018 | 24 | |
| 16 | 2020 | 24 | |
| 17 | 2018 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2019 | 18 | |
| 20 | 2022 | 17 |
About Narjust Duma
Narjust Duma is a scholar working on Oncology, Gender Studies, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Economics and Econometrics, having authored 95 papers that have together received 3.5k indexed citations. Recurring topics across this work include Diversity and Career in Medicine (17 papers), Economic and Financial Impacts of Cancer (10 papers), Advances in Oncology and Radiotherapy (9 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Global Cancer Incidence and Screening (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (383 citations), Pulmonary and Respiratory Medicine (808 citations), Public Health, Environmental and Occupational Health (372 citations) and Gender Studies (138 citations). Narjust Duma has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Julian R. Molina, Rafael Santana-Dávila, Jesus Vera Aguilera, Yucai Wang, Aaron S. Mansfield, Alex A. Adjei, Þorvarður R. Hálfdánarson, Jonas Paludo, Ronald S. Go and Konstantinos Leventakos. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, JAMA Oncology, Blood and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.